Emergent BioSolutions (EBS) Cash from Investing Activities Growth (3y) (2013 - 2026)
Emergent BioSolutions (EBS) Cash from Investing Activities Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 8.16% |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 26.15% |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 75.05% |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | -129.09% |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | -2.94% |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -212.48% |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 37.22% |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | -55.44% |
| 10 | Emergent BioSolutions | 427.92 Mn | 266.42 Mn | 84.10 Mn | 45.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45.83% |
| Dec 31, 2025 | 55.88% |
| Sep 30, 2025 | 76.78% |
| Jun 30, 2025 | 36.37% |
| Mar 31, 2025 | 56.70% |
| Dec 31, 2024 | 37.94% |
| Sep 30, 2024 | 59.12% |
| Jun 30, 2024 | 59.05% |
| Mar 31, 2024 | 42.26% |
| Dec 31, 2023 | 32.40% |
| Sep 30, 2023 | 25.50% |
| Jun 30, 2023 | 97.59% |
| Mar 31, 2023 | 14.55% |
| Dec 31, 2022 | -7.94% |
| Sep 30, 2022 | -160.86% |
| Jun 30, 2022 | -10.03% |
| Mar 31, 2022 | -14.59% |
| Dec 31, 2021 | 62.21% |
| Sep 30, 2021 | -28.36% |
| Jun 30, 2021 | -82.63% |